Nippon India Pharma Fund-Growth Plan-Growth Option

arrow-up
NAV
₹ 562.2939 ₹ 1.92 (0.34 %)
as on 10-07-2026
Asset Size (AUM)
8,634.84 Cr
Launch Date
Jun 01, 2004
Investment Objective
The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related or fixed income securities of Pharma and other associated companies. There is no assurance that the investment objective of the Scheme will be achieved.
Minimum Investment 5000.0
Minimum Top-up 1000.0
Investment Returns Since Launch in Jun 01, 2004
arrow-up

19.99

%
3 M
6 M
1 Y
3 Y
10 Y
Inception
Sharp Ratio
1.02 %
Expense Ratio
1.78%
Volatility
14.36 %
Fund House
Nippon India Mutual Fund
Fund Manager
Sailesh Raj Bhan
Key Features
Scheme description
This fund has higher ups and downs compared to other equity funds but can give much higher returns. Investment in this fund can be made for a horizon of at least 5-7 years or more
Minimum Purchase Application Amount
Rs. 5000.0 (plus in multiples of Rs. 1000.0)

Entry Load
Not applicable
Exit Load
1% on or before 1M, Nil after 1M
Indicative Investment Horizon
5 Years and above
Asset Allocation
Fund's historical return comparison with other asset classes
Fund Performance
Fund's historical return comparison with other asset classes
Performance

Scheme Performance (%)

Data as on - 10-07-2026

Yearly Performance (%)

Investment Returns Calculator
Rolling returns are the annualized returns of the scheme taken for a specified period (rolling returns period) on every day/week/month and taken till the last day of the duration. In this chart we are showing the annualized returns over the rolling returns period on every day from the start date and comparing it with the benchmark. Rolling returns is the best measure of a fund's performance. Trailing returns have a recency bias and point to point returns are specific to the period in consideration. Rolling returns, on the other hand, measures the fund's absolute and relative performance across all timescales, without bias.
Peer Comparison
Scheme Name Inception Date 1 Year Return % 2 Year Return % 3 Year Return % 5 Year Return % 10 Year Return %
Nippon India Pharma Fund-Growth Plan-Growth Option 01-06-2004 9.18 10.17 20.95 12.78 15.04
HDFC Pharma And Healthcare Fund - Growth Option 04-10-2023 21.27 22.43 0.0 0.0 0.0
Kotak Healthcare Fund - Regular Plan - Growth Option 11-12-2023 19.89 15.67 0.0 0.0 0.0
WhiteOak Capital Pharma And Heathcare Fund Regular Plan Growth 06-02-2024 19.12 20.66 0.0 0.0 0.0
Aditya Birla Sun Life Pharma And Healthcare Fund-Regular-Growth 05-07-2019 15.93 11.97 22.99 13.27 0.0
PGIM India Healthcare Fund - Regular Plan - Growth Option 19-11-2024 15.88 0.0 0.0 0.0 0.0
Mirae Asset Healthcare Fund -Regular Growth 10-07-2018 15.51 13.7 23.95 14.24 0.0
SBI Healthcare Opportunities Fund - Regular Plan -Growth 14-07-1999 15.25 16.2 24.31 16.46 13.53
UTI Healthcare Fund - Regular Plan - Growth Option 05-08-2005 14.95 15.67 25.96 14.55 13.62
Bajaj FInserv Healthcare Fund - Regular - Growth 27-12-2024 14.32 0.0 0.0 0.0 0.0
Portfolio Analysis
Portfolio as on
Sector Allocation
Sector Allocation (%)
Portfolio Holdings
Company Allocation (%)
Sector Allocation
Portfolio Holdings